Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ron Dick

A/Prof Ron Dick

LDL Management Demystified

A/Prof Samantha Hocking

A/Prof Samantha Hocking

Tirzepatide for Chronic Weight Management

Dr Rupert Hinds

Dr Rupert Hinds

Diarrhoea in Kids – When to Worry

Dr Alberto Pinzon Charry

Dr Alberto Pinzon Charry

Urticaria Management in Primary Care

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 29 October 2024